Study Summary
This trial will test how well the FDG-PET scan and blood tests for HPV can detect leftover cervical cancer cells after treatment.
Eligible Conditions
- Cervical Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: up to 5 years
Up to 3 months
Plasma HPV DNA levels
up to 5 years
Progression-free survival rate
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
FDG PET Scan
1 of 1
Experimental Treatment
64 Total Participants · 1 Treatment Group
Primary Treatment: [18-F]- FDG - PET · No Placebo Group · N/A
FDG PET Scan
DiagnosticTest
Experimental Group · 1 Intervention: [18-F]- FDG - PET · Intervention Types: DiagnosticTestTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years
Who is running the clinical trial?
Sunnybrook Health Sciences CentreOTHER
604 Previous Clinical Trials
1,469,123 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,380 Previous Clinical Trials
473,375 Total Patients Enrolled
Eligibility Criteria
Age 18+ · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments